Trial Condition(s):

Hemophilia A

Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study within an Existing Registry

Bayer Identifier:

19866

ClinicalTrials.gov Identifier:

NCT03603275

EudraCT Number:

Not Available

Terminated/Withdrawn

Trial Purpose

This US study aims to assess hemophilia A patient characteristics and reasons for switching from both patient/caregiver and physician perspectives. For this purpose, this research study will include hemophilia A patients who have switched from an existing therapy to Kovaltry or Jivi. In doing so, real world evidence will be obtained from both patient and physician perspectives offering key insights for effective therapeutic management of patients with hemophilia A and to more fully understand what drives patient switching from a patient perspective and a physician perspective.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
3
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Kovaltry (Antihemophilic Factor [Recombinant], BAY81-8973)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Yale Hemophilia Treatment Center

New Haven, United States, 06510

Status
Completed
 
Locations

Maine Hemophilia and Thrombosis Center

Scarborough, United States, 04074

Status
Completed
 
Locations

Dartmouth-Hitchcock Comprehensive Hemophilia and Thrombosis Center

Lebanon, United States, 03756

Status
Completed
 
Locations

Boston Hemophilia Center at Children's Hospital of Boston/Brigham Women's

Boston, United States, 02115

Status
Completed
 
Locations

Children's Hospital of Philadelphia (CHOP)

Philadelphia, United States, 01914

Status
Completed
 
Locations

Weill Cornell Medicine

New York, United States, 10065

Status
Completed
 
Locations

Mary M. Gooley Hemophilia Center, Inc.

Rochester, United States, 14621

Status
Completed
 
Locations

Children's National Medical Center

Washington, United States, 20010

Status
Completed
 
Locations

Hemophilia Center of Western Pennsylvania

Pittsburgh, United States, 15213

Status
Completed
 
Locations

The Johns Hopkins University Hemophilia Treatment Center

Baltimore, United States, 21205

Status
Completed
 
Locations

Penn Comprehensive Hemophilia and Thrombophilia Program / Hospital UPENN

Philadelphia, United States, 19104

Status
Completed
 
Locations

St. Jude Children's Research Hospital

Memphis, United States, 38105

Status
Completed
 
Locations

St. Josephs Hemophilia Treatment Center

Tampa, United States, 33607

Status
Completed
 
Locations

Emory / Children's Healthcare of Atlanta

Atlanta, United States, 30322

Status
Completed
 
Locations

Johns Hopkins All Children's Hospital

St. Petersburgh, United States, 33701

Status
Completed
 
Locations

Indiana Hemophilia and Thrombosis Center IHTC

Indianapolis, United States, 46260

Status
Completed
 
Locations

Michigan State University Center for Bleeding Disorders & Clotting Disorders

East Lansing, United States, 48824

Status
Completed
 
Locations

Univ of Michigan Hemophilia and Coagulation Disorders

Ann Arbor, United States, 48109

Status
Completed
 
Locations

Bleeding and Clotting Disorders Institute

Peoria, United States, 61615

Status
Completed
 
Locations

Blood Center of Wisconsin, Inc. /Childrens Hosp of Wisconsin

Milwaukee, United States, 53226

Status
Completed
 
Locations

Louisiana Center for Bleeding and Clotting Disorders / Tulane

New Orleans, United States, 70112

Status
Completed
 
Locations

UT Southwestern/Children's Health Dallas

Dallas, United States, 75390

Status
Completed
 
Locations

Children's Mercy Hospital (Kansas City)

Kansas City, United States, 64108

Status
Completed
 
Locations

University of Colorado Denver Hemophilia and Thrombosis Center

Aurora, United States, 80045

Status
Completed
 
Locations

University of California, San Diego

La Jolla, United States, 92093

Status
Completed
 
Locations

BloodWorks (Puget Sound)

Seattle, United States, 98104

Status
Completed
 
Locations

Oregon Health & Science University

Portland, United States, 97239

Status
Completed
 

Trial Design